Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
The Journal of pharmacology and experimental therapeutics·2002
A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.
Pharmacology, biochemistry, and behavior·2002
Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.
Bioorganic & medicinal chemistry letters·2001
Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.
The Journal of pharmacology and experimental therapeutics·2000
Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.
Pharmacology, biochemistry, and behavior·1996